In recent years, CNPase has been identified as a novel heart failure treatment strategy (Wang et al., 2021) and has been discovered to alleviate heart hypertrophy by enhancing mitochondrial energy production (Tan et al., 2021). This evidence concerns the gene CNP and cardiac hypertrophy.